Your browser doesn't support javascript.
loading
Cardiac Sympathetic Denervation as a Treatment for Ventricular Arrhythmias Refractory to Conventional Treatment: A Case Series.
Álvarez-Ortega, Carolina; Gómez-Martínez, Josué Daniel; Cardona-Gallardo, María Alejandra; Torres-España, Nicolás Felipe; Pava-Molano, Luis Fernando; Sánchez-Ortiz, Álvaro Ignacio; Velásquez-Galvis, Mauricio.
Afiliação
  • Álvarez-Ortega C; Fundación Valle del Lili, Centro de Investigaciones Clínicas Cali, Colombia.
  • Gómez-Martínez JD; Fundación Valle del Lili, Centro de Investigaciones Clínicas Cali, Colombia.
  • Cardona-Gallardo MA; Universidad Icesi, Facultad de Ciencias de la Salud Cali, Colombia.
  • Torres-España NF; Fundación Valle del Lili, Departamento de Cirugía Cali, Colombia.
  • Pava-Molano LF; Fundación Valle del Lili, Departamento de Cardiología y Electrofisiología Cali, Colombia.
  • Sánchez-Ortiz ÁI; Fundación Valle del Lili, Departamento de Cirugía, División de Cirugía de Tórax Cali, Colombia.
  • Velásquez-Galvis M; Fundación Valle del Lili, Departamento de Cirugía, División de Cirugía de Tórax Cali, Colombia.
Interv Cardiol ; 19: e06, 2024.
Article em En | MEDLINE | ID: mdl-38808282
ABSTRACT

Background:

Ventricular arrhythmias are a leading cause of sudden death. The objective of this study was to characterise the results of patients with ventricular arrhythmias refractory to standard medical management, undergoing Video-assisted thoracoscopic cardiac sympathetic denervation (VAT-CSD) during 2012-2022 in Cali, Colombia.

Methods:

This was an observational retrospective study, using the Institutional General Thoracic Surgery Database for patient identification and retrospectively reviewing the clinical charts for data description and analysis.

Results:

Clinical records of 19 patients who underwent VAT-CSD for ventricular arrhythmia were analysed. The patients were predominantly male (73.7%) with an mean age of 62 years. Ischaemic heart disease was the main underlying condition (52.6%); all individuals had a diagnosis of heart failure, with comorbidities such as hypertension (63.1%), acute MI (57.8%) and diabetes (26.3%) also present. The procedure was performed bilaterally in 89.4% of cases and was successful with minimal perioperative complications. Postoperative follow-up showed improvement in symptoms, including a significant reduction in the number of ICD shocks and emergency department visits.

Conclusion:

VAT-CSD is a viable, safe and palliative therapeutic option for patients with ventricular arrhythmias who have not responded to conventional treatments, achieving a significant decrease in symptoms with low mortality and perioperative complications.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Interv Cardiol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Interv Cardiol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Reino Unido